DGX vs XGN
Quest Diagnostics Incorporated Common Stock · Exagen Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | DGX | XGN |
|---|---|---|
| Price | $228.39 | $8.19 |
| Market Cap | $25.21B | $198.41M |
| P/E | 25.41 | — |
| P/B | 3.35 | 16.24 |
| P/S | 2.28 | 2.98 |
| ROE | 13.2% | -163.3% |
| Net Margin | 9.0% | -30.0% |
| Gross Margin | 32.9% | 58.3% |
| Revenue Growth | 11.8% | 19.7% |
| Dividend Yield | 0.79% | — |
| EPS | $8.99 | -$0.82 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.